Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1976 Nov;58(3):462P.

Prostaglandin E2 released from the kidneys of genetic hypertensive rats contributes to the vasoconstrictor supersensitivity to angiotensin II in vitro [proceedings].

J M Armstrong, N Lattimer
PMCID: PMC1667573  PMID: 990638

Full text

PDF

Page 462P

462P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aiken J. W., Vane J. R. Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin. J Pharmacol Exp Ther. 1973 Mar;184(3):678–687. [PubMed] [Google Scholar]
  2. Armstrong J. M., Blackwell G. J., Flower R. J., McGiff J. C., Mullane K. M., Vane J. R. Genetic hypertension in rats is accompanied by a defect in renal prostaglandin catabolism. Nature. 1976 Apr 15;260(5552):582–586. doi: 10.1038/260582a0. [DOI] [PubMed] [Google Scholar]
  3. Malik K. U., McGiff J. C. Modulation by prostaglandins of adrenergic transmission in the isolated perfused rabbit and rat kidney. Circ Res. 1975 May;36(5):599–609. doi: 10.1161/01.res.36.5.599. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES